HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Carson divesting Cutex nail care business; CEO Keith stepping down.

This article was originally published in The Rose Sheet

Executive Summary

CUTEX PUT ON SELLING BLOCK BY CARSON in an effort to narrow the firm's "strategic focus on the worldwide ethnic personal care business," Carson announced June 4. The company has engaged the investment banking firm Merrill Lynch to assist with the planned sale of the Cutex nail polish and nail polish remover business, which the company acquired a little over a year ago ("The Rose Sheet" April 7, 1997, p. 6). The move comes amidst a number of other corporate restructuring steps designed to improve Carson's performance and profitability.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005479

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel